Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease.

Gilch S, Winklhofer KF, Groschup MH, Nunziante M, Lucassen R, Spielhaupter C, Muranyi W, Riesner D, Tatzelt J, Schätzl HM.

EMBO J. 2001 Aug 1;20(15):3957-66.

2.

Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.

Gilch S, Nunziante M, Ertmer A, Schätzl HM.

Vet Microbiol. 2007 Aug 31;123(4):377-86. Epub 2007 Apr 8. Review.

PMID:
17493775
3.

The role of rafts in the fibrillization and aggregation of prions.

Pinheiro TJ.

Chem Phys Lipids. 2006 Jun;141(1-2):66-71. Epub 2006 Mar 27. Review.

PMID:
16647049
4.

Prion protein self-interactions: a gateway to novel therapeutic strategies?

Rigter A, Langeveld JP, van Zijderveld FG, Bossers A.

Vaccine. 2010 Nov 16;28(49):7810-23. doi: 10.1016/j.vaccine.2010.09.012. Epub 2010 Oct 20. Review.

PMID:
20932496
5.

Aptamers against prion proteins and prions.

Gilch S, Schätzl HM.

Cell Mol Life Sci. 2009 Aug;66(15):2445-55. doi: 10.1007/s00018-009-0031-5. Epub 2009 Apr 25. Review.

PMID:
19396399
6.

Prion encephalopathies of animals and humans.

Prusiner SB.

Dev Biol Stand. 1993;80:31-44. Review.

PMID:
8270114
7.

Genetic and infectious prion diseases.

Prusiner SB.

Arch Neurol. 1993 Nov;50(11):1129-53. Review.

PMID:
8105771
8.

Prion protein biosynthesis and its emerging role in neurodegeneration.

Chakrabarti O, Ashok A, Hegde RS.

Trends Biochem Sci. 2009 Jun;34(6):287-95. doi: 10.1016/j.tibs.2009.03.001. Epub 2009 May 15. Review.

9.

Transgenetic investigations of prion diseases of humans and animals.

Prusiner SB.

Philos Trans R Soc Lond B Biol Sci. 1993 Feb 27;339(1288):239-54. Review.

PMID:
8097053
10.

Molecular mechanisms of neurotoxicity of pathological prion protein.

Castilla J, Hetz C, Soto C.

Curr Mol Med. 2004 Jun;4(4):397-403. Review.

PMID:
15354870
11.

Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.

Singh J, Udgaonkar JB.

Biochemistry. 2015 Jul 28;54(29):4431-42. doi: 10.1021/acs.biochem.5b00605. Epub 2015 Jul 17. Review.

PMID:
26171558
12.

High-resolution structure of infectious prion protein: the final frontier.

Diaz-Espinoza R, Soto C.

Nat Struct Mol Biol. 2012 Apr 4;19(4):370-7. doi: 10.1038/nsmb.2266. Review.

13.

Prion protein transgenes and the neuropathology in prion diseases.

DeArmond SJ, Prusiner SB.

Brain Pathol. 1995 Jan;5(1):77-89. Review.

PMID:
7767493
14.

Transgenic models of prion disease.

Scott MR, Supattapone S, Nguyen HO, DeArmond SJ, Prusiner SB.

Arch Virol Suppl. 2000;(16):113-24. Review.

PMID:
11214913
15.

The role of lipid rafts in prion protein biology.

Lewis V, Hooper NM.

Front Biosci (Landmark Ed). 2011 Jan 1;16:151-68. Review.

PMID:
21196164
16.

Genetics of prion diseases and prion diversity in mice.

Carlson GA, DeArmond SJ, Torchia M, Westaway D, Prusiner SB.

Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):363-9. Review.

PMID:
7913753
17.

PrP knock-out and PrP transgenic mice in prion research.

Weissmann C, Flechsig E.

Br Med Bull. 2003;66:43-60. Review.

PMID:
14522848
18.

Creutzfeldt-Jakob disease and scrapie prions.

Prusiner SB.

Alzheimer Dis Assoc Disord. 1989 Spring-Summer;3(1-2):52-78. Review.

PMID:
2568118
19.
20.

Prions: protein only or something more? Overview of potential prion cofactors.

Fasano C, Campana V, Zurzolo C.

J Mol Neurosci. 2006;29(3):195-214. Review.

PMID:
17085779

Supplemental Content

Support Center